1. Home
  2. OCGN vs NVEC Comparison

OCGN vs NVEC Comparison

Compare OCGN & NVEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • NVEC
  • Stock Information
  • Founded
  • OCGN 2013
  • NVEC 1989
  • Country
  • OCGN United States
  • NVEC United States
  • Employees
  • OCGN N/A
  • NVEC N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • NVEC Semiconductors
  • Sector
  • OCGN Health Care
  • NVEC Technology
  • Exchange
  • OCGN Nasdaq
  • NVEC Nasdaq
  • Market Cap
  • OCGN 338.2M
  • NVEC 373.9M
  • IPO Year
  • OCGN N/A
  • NVEC 1996
  • Fundamental
  • Price
  • OCGN $0.99
  • NVEC $82.95
  • Analyst Decision
  • OCGN Strong Buy
  • NVEC
  • Analyst Count
  • OCGN 3
  • NVEC 0
  • Target Price
  • OCGN $5.33
  • NVEC N/A
  • AVG Volume (30 Days)
  • OCGN 3.5M
  • NVEC 12.4K
  • Earning Date
  • OCGN 11-08-2024
  • NVEC 10-23-2024
  • Dividend Yield
  • OCGN N/A
  • NVEC 4.85%
  • EPS Growth
  • OCGN N/A
  • NVEC N/A
  • EPS
  • OCGN N/A
  • NVEC 3.33
  • Revenue
  • OCGN $7,263,000.00
  • NVEC $27,381,423.00
  • Revenue This Year
  • OCGN N/A
  • NVEC N/A
  • Revenue Next Year
  • OCGN N/A
  • NVEC N/A
  • P/E Ratio
  • OCGN N/A
  • NVEC $24.61
  • Revenue Growth
  • OCGN 112.62
  • NVEC N/A
  • 52 Week Low
  • OCGN $0.35
  • NVEC $68.23
  • 52 Week High
  • OCGN $2.11
  • NVEC $90.24
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 50.03
  • NVEC 62.85
  • Support Level
  • OCGN $0.91
  • NVEC $73.31
  • Resistance Level
  • OCGN $0.98
  • NVEC $83.49
  • Average True Range (ATR)
  • OCGN 0.07
  • NVEC 2.22
  • MACD
  • OCGN 0.02
  • NVEC 0.61
  • Stochastic Oscillator
  • OCGN 40.08
  • NVEC 94.70

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

Share on Social Networks: